Acne alone, once FDA approved, makes BOT a $5 stock. Antimicrobial, if approved by the FDA, makes it another $5. If BOT get to selling $500m worth of SB then there's another $3-4 to add to the SP. Even is Rosacea is only worth $2, I have no doubt we're looking at a +$15 SP. But that is 3 or so years away, and I doubt we'll get there without being taken out long before (but in the $3-$5 range).
BOT - Anything but charting, page-5738
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 37.0¢ | $771.7K | 2.030M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 197472 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 131489 | 16 |
View Market Depth
| Last trade - 13.29pm 09/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |